OH-Radical Oxidation of Lung Surfactant Protein B on Aqueous Surfaces

Atmospheric Intermediates at the Air-Water Interface

The air-water interface (AWI) is a ubiquitous reaction field different from the bulk phase where unexpected reactions and physical processes often occur. The AWI is a region where air contacts cloud droplets, aerosol particles, the ocean surface, and biological surfaces such as fluids that line human epithelia. In Earth's atmosphere, short-lived intermediates are expected to be generated at the AWI during multiphase reactions. Recent experimental developments have enabled the direct detection of atmospherically relevant, short-lived intermediates at the AWI. For example, spray ionization mass spectrometric analysis of water microjets exposed to a gaseous mixture of ozone and water vapor combined with a 266 nm laser flash photolysis system (LFP-SIMS) has been used to directly probe organic peroxyl radicals (RO2·) produced by interfacial hydroxyl radicals (OH·) + organic compound reactions. OH· emitted immediately after the laser flash photolysis of carboxylic acid at the gas-liquid interface have been directly detected by time-resolved, laser-induced florescence techniques that can be used to study atmospheric multiphase photoreactions. In this Featured Article, we show some recent experimental advances in the detection of atmospherically important intermediates at the AWI and the associated reaction mechanisms. We also discuss current challenges and future prospects for atmospheric multiphase chemistry.

Effects of Metal Ions on Aqueous-Phase Decomposition of α-Hydroxyalkyl-Hydroperoxides Derived from Terpene Alcohols

We report the results of a mass spectrometric study of the effects of atmospherically relevant metal ions on the decomposition of α-hydroxyalkyl-hydroperoxides (α-HHs) derived from ozonolysis of α-terpineol in aqueous solutions. By direct mass spectrometric detection of chloride adducts of α-HHs, we assessed the temporal profiles of α-HHs and other products in the presence of metal ions. In addition, reactions between α-HHs and FeCl₂ in the presence of excess DMSO showed that the amount of hydroxyl radicals formed in a mixture of α-terpineol, O₃, and FeCl₂ was 5.7 ± 0.8% of the amount formed in a mixture of H₂O₂ and FeCl₂. The first-order rate constants for the decay of α-HHs produced by ozonolysis of α-terpineol in the presence of 5 mM acetate buffer at a pH of 5.1 ± 0.1 were determined to be (4.5 ± 0.1) × 10^-4 s^-1 (no metal ions), (4.7 ± 0.2) × 10^-4 s^-1 (with 0.05 mM Fe²⁺), (4.7 ± 0.1) × 10^-4 s^-1 (with 0.05 mM Zn²⁺), and (4.8 ± 0.2) × 10^-4 s^-1 (with 0.05 mM Cu²⁺). We propose that in acidic aqueous media, the reaction of α-HHs with Fe²⁺ is outcompeted by H⁺-catalyzed decomposition of α-HHs, which produces the corresponding aldehydes and H₂O₂, which can in turn react with Fe²⁺ to form hydroxyl radicals.

Pulmonary surfactant: a unique biomaterial with life-saving therapeutic applications

Pulmonary surfactant is a complex lipoprotein mixture secreted into the alveolar lumen by type 2 pneumocytes, which is composed by tens of different lipids (approximately 90% of its entire mass) and surfactant proteins (approximately 10% of the mass). It is crucially involved in maintaining lung homeostasis by reducing the values of alveolar liquid surface tension close to zero at end-expiration, thereby avoiding the alveolar collapse, and assembling a chemical and physical barrier against inhaled pathogens. A deficient amount of surfactant or its functional inactivation is directly linked to a wide range of lung pathologies, including the neonatal respiratory distress syndrome. This paper reviews the main biophysical concepts of surfactant activity and its inactivation mechanisms, and describes the past, present and future roles of surfactant replacement therapy, focusing on the exogenous surfactant preparations marketed worldwide and new formulations under development. The closing section describes the pulmonary surfactant in the context of drug delivery. Thanks to its peculiar composition, biocompatibility, and alveolar spreading capability, the surfactant may work not only as a shuttle to the branched anatomy of the lung for other drugs but also as a modulator for their release, opening to innovative therapeutic avenues for the treatment of several respiratory diseases.